Select Publications
Journal articles
2024, 'Codesign of health technology interventions to support best-practice perioperative care and surgical waitlist management.', BMJ Health Care Inform, 31, http://dx.doi.org/10.1136/bmjhci-2023-100928
,2024, 'The Clinical Utility of Gallium-68-DOTATATE Positron Emission Tomography Scanning in Medullary Thyroid Cancer', Endocrine Practice, 30, pp. 218 - 224, http://dx.doi.org/10.1016/j.eprac.2023.12.008
,2024, 'Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study', Thyroid, 34, pp. 167 - 176, http://dx.doi.org/10.1089/thy.2023.0279
,2024, 'Risk of malignancy in radiologically and cytologically discordant thyroid nodules, based on Thyroid Imaging, Reporting and Data System (TI-RADS) and Bethesda classifications', BJS Open, 8, http://dx.doi.org/10.1093/bjsopen/zrad117
,2024, 'Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinoma', Histopathology, http://dx.doi.org/10.1111/his.15141
,2024, 'Response to Letter to the Editor From Devgan and Mayilvaganan: “Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma”', Journal of Clinical Endocrinology and Metabolism, 109, pp. E437, http://dx.doi.org/10.1210/clinem/dgad380
,2023, 'A Critical Assessment of Diagnostic Criteria for the Tall Cell Subtype of Papillary Thyroid Carcinoma—How Much? How Tall? And When Is It Relevant?', Endocrine Pathology, 34, pp. 461 - 470, http://dx.doi.org/10.1007/s12022-023-09788-8
,2023, 'A Detailed Histologic and Molecular Assessment of the Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma', Modern Pathology, 36, http://dx.doi.org/10.1016/j.modpat.2023.100329
,2023, 'Management of Medullary Thyroid Cancer: Patterns of Recurrence and Outcomes of Reoperative Surgery', Oncologist, 28, pp. 1064 - 1071, http://dx.doi.org/10.1093/oncolo/oyad232
,2023, 'Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma', The Journal of clinical endocrinology and metabolism, 108, pp. 2626 - 2634, http://dx.doi.org/10.1210/clinem/dgad173
,2023, 'Minimally invasive adrenalectomy: a cohort study of surgical approach and outcomes', ANZ Journal of Surgery, 93, pp. 2222 - 2228, http://dx.doi.org/10.1111/ans.18443
,2023, 'Diffuse sclerosing variant papillary thyroid carcinoma has worse survival than classic papillary thyroid carcinoma: a meta-analysis', Endocrine-Related Cancer, 30, http://dx.doi.org/10.1530/ERC-22-0348
,2023, 'Putting Patients, Not Clinicians, at the Center of Care to Improve Management of Low-risk Thyroid Cancer', JAMA Otolaryngology - Head and Neck Surgery, 149, pp. 459 - 461, http://dx.doi.org/10.1001/jamaoto.2023.0102
,2023, 'Genotype–Phenotype Correlations and Clinical Outcomes in 155 Cases of Pheochromocytoma and Paraganglioma', World Journal of Surgery, 47, pp. 690 - 698, http://dx.doi.org/10.1007/s00268-022-06862-w
,2023, 'The Presence of Typical “BRAFV600E-Like” Atypia in Papillary Thyroid Carcinoma is Highly Specific for the Presence of the BRAFV600E Mutation', Endocrine Pathology, 34, pp. 112 - 118, http://dx.doi.org/10.1007/s12022-022-09747-9
,2023, 'The Prognostic Impact of Extent of Vascular Invasion in Follicular Thyroid Carcinoma', World Journal of Surgery, 47, pp. 412 - 420, http://dx.doi.org/10.1007/s00268-022-06696-6
,2023, 'Development of a novel clinical support tool for active surveillance of low risk papillary thyroid cancer', Frontiers in Endocrinology, 14, http://dx.doi.org/10.3389/fendo.2023.1160249
,2023, 'Lobectomy and completion thyroidectomy rates increase after the 2015 American Thyroid Association Differentiated Thyroid Cancer Guidelines update.', Endocr Oncol, 3, pp. e220095, http://dx.doi.org/10.1530/EO-22-0095
,2023, 'Clinicopathological and genetic characteristics of diffuse sclerosing papillary thyroid carcinoma', Pathology, 55, pp. S53 - S53, http://dx.doi.org/10.1016/j.pathol.2022.12.169
,2023, 'Massive Biochemically Silent Pheochromocytoma Masquerading as Nonfunctioning Adrenocortical Cancer.', JCEM Case Rep, 1, pp. luad061, http://dx.doi.org/10.1210/jcemcr/luad061
,2022, 'Unexpected deaths after endocrine surgery: learning from rare events using a national audit of surgical mortality', British Journal of Surgery, 109, pp. 1164 - 1171, http://dx.doi.org/10.1093/bjs/znac276
,2022, 'A Retrospective Cohort Study with Validation of Predictors of Differentiated Thyroid Cancer Outcomes', Thyroid, 32, pp. 1201 - 1210, http://dx.doi.org/10.1089/thy.2021.0563
,2022, 'Outcomes of Papillary Thyroid Microcarcinoma Presenting with Palpable Lateral Lymphadenopathy', Thyroid, 32, pp. 1086 - 1093, http://dx.doi.org/10.1089/thy.2022.0109
,2022, 'Factors That Inform Individual Decision Making between Active Surveillance, Hemithyroidectomy and Total Thyroidectomy for Low-Risk Thyroid Cancer: A Scoping Review', Thyroid, 32, pp. 807 - 818, http://dx.doi.org/10.1089/thy.2021.0646
,2022, 'Thyroidectomy in Australia 2022: lessons from 21,000 consecutive cases', ANZ Journal of Surgery, 92, pp. 1626 - 1630, http://dx.doi.org/10.1111/ans.17783
,2022, 'Applying the ‘three buckets’ theory of situational awareness to surgical training: an updated framework', ANZ Journal of Surgery, 92, pp. 1498 - 1501, http://dx.doi.org/10.1111/ans.17741
,2022, 'ASO Author Reflections: Medullary Thyroid Cancer—Establishing Treatment Paradigms in a Rapidly Evolving Therapeutic Landscape', Annals of Surgical Oncology, 29, pp. 72 - 73, http://dx.doi.org/10.1245/s10434-021-10989-w
,2022, 'ASO Visual Abstract: Outcomes of Advanced MTC in the Era of Targeted Therapy', Annals of surgical oncology, 29, pp. 74, http://dx.doi.org/10.1245/s10434-021-11032-8
,2022, 'International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma', Journal of Clinical Oncology, 40, pp. 96 - 103, http://dx.doi.org/10.1200/JCO.21.01329
,2022, 'Outcomes of Advanced Medullary Thyroid Carcinoma in the Era of Targeted Therapy', Annals of Surgical Oncology, 29, pp. 64 - 71, http://dx.doi.org/10.1245/s10434-021-10980-5
,2022, 'Tumour volume is a predictor of lymphovascular invasion in differentiated small thyroid cancer.', Endocr Oncol, 2, pp. 42 - 49, http://dx.doi.org/10.1530/EO-22-0066
,2021, 'Correction to: Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited Treatment (Annals of Surgical Oncology, (2021), 28, 12, (7520-7530), 10.1245/s10434-021-10146-3)', Annals of Surgical Oncology, 28, pp. 891, http://dx.doi.org/10.1245/s10434-021-10440-0
,2021, 'Thyroid cancer clinicians' views and experiences of delayed treatment during the COVID-19 pandemic: An international cross-sectional survey', ANZ Journal of Surgery, 91, pp. 2562 - 2564, http://dx.doi.org/10.1111/ans.17128
,2021, 'What is the Accuracy of the ACS-NSQIP Surgical Risk Calculator in Emergency Abdominal Surgery? A Meta-Analysis', Journal of Surgical Research, 268, pp. 300 - 307, http://dx.doi.org/10.1016/j.jss.2021.07.009
,2021, 'Focused parathyroidectomy without intraoperative parathyroid hormone measurement in primary hyperparathyroidism: Still a valid approach?', Surgery (United States), 170, pp. 1383 - 1388, http://dx.doi.org/10.1016/j.surg.2021.05.030
,2021, 'Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited Treatment', Annals of Surgical Oncology, 28, pp. 7520 - 7530, http://dx.doi.org/10.1245/s10434-021-10146-3
,2021, 'Pros and cons of hemi-thyroidectomy for low-risk differentiated thyroid cancer', ANZ Journal of Surgery, 91, pp. 1704 - 1710, http://dx.doi.org/10.1111/ans.16553
,2021, 'Erratum: Correction to: The PanSurg-PREDICT Study: Endocrine Surgery During the COVID-19 Pandemic (World journal of surgery (2021) 45 8 (2315-2324))', World journal of surgery, 45, pp. 2325, http://dx.doi.org/10.1007/s00268-021-06171-8
,2021, 'The PanSurg-PREDICT Study: Endocrine Surgery During the COVID-19 Pandemic', World Journal of Surgery, 45, pp. 2315 - 2324, http://dx.doi.org/10.1007/s00268-021-06099-z
,2021, 'Change in Practice of Radioactive Iodine Administration in Differentiated Thyroid Cancer: A Single-Centre Experience', European Thyroid Journal, 10, pp. 408 - 415, http://dx.doi.org/10.1159/000516358
,2021, 'Prophylactic central lymph node dissection informs the decision of radioactive iodine ablation in papillary thyroid cancer', American Journal of Surgery, 221, pp. 886 - 892, http://dx.doi.org/10.1016/j.amjsurg.2020.08.012
,2021, 'An unusual case of a penetrating neck injury (PNI) illustrating the use of a “no zone” approach for the management of this injury and a review of the literature', Trauma Case Reports, 32, http://dx.doi.org/10.1016/j.tcr.2021.100402
,2021, 'Predicting distant metastatic disease in differentiated thyroid cancer: a matched case–control study', ANZ Journal of Surgery, 91, pp. 716 - 723, http://dx.doi.org/10.1111/ans.16652
,2021, 'Delays to Low-risk Thyroid Cancer Treatment during COVID-19 - Refocusing from What Has Been Lost to What May Be Learned and Gained', JAMA Otolaryngology - Head and Neck Surgery, 147, pp. 5 - 6, http://dx.doi.org/10.1001/jamaoto.2020.3878
,2020, 'Thyroid cancer in the age of COVID-19', Endocrine-Related Cancer, 27, pp. R407 - R416, http://dx.doi.org/10.1530/ERC-20-0279
,2020, 'A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis', American Journal of Surgical Pathology, 44, pp. 1419 - 1428, http://dx.doi.org/10.1097/PAS.0000000000001505
,2020, 'Key microrna’s and their targetome in adrenocortical cancer', Cancers, 12, pp. 1 - 23, http://dx.doi.org/10.3390/cancers12082198
,2020, 'Molecular markers guiding thyroid cancer management', Cancers, 12, pp. 1 - 26, http://dx.doi.org/10.3390/cancers12082164
,2020, 'Letter to the Editor: Reoperation for Bleeding After Thyroid and Parathyroid Surgery: Incidence, Risk Factors, Prevention, and Management', World Journal of Surgery, 44, pp. 2441 - 2442, http://dx.doi.org/10.1007/s00268-020-05460-y
,2020, 'Utility of the American College of Surgeons National Surgical Quality Improvement Program surgical risk calculator in predicting mortality in an Australian acute surgical unit', ANZ Journal of Surgery, 90, pp. 746 - 751, http://dx.doi.org/10.1111/ans.15892
,